Educational Disclaimer: This case study is for educational and informational purposes only. It does not constitute medical advice, clinical guidance, or a substitute for professional psychiatric evaluation. All diagnostic criteria referenced are from the DSM-5-TR (APA, 2022). Clinicians should rely on their professional training, direct patient assessment, and current evidence-based guidelines when making diagnostic and treatment decisions.

Clinical Vignette

Patient: "Mr. K," 30-year-old unemployed musician, brought to the emergency department by his brother after 2 weeks of escalating paranoid behavior and grandiose claims.

Chief Concern: "The record labels have implanted a chip in my brain to steal my music. I can hear them discussing their plans through the walls."

History of Present Illness: Mr. K's brother reports a 3-year pattern of episodic mood disturbance alternating with periods of psychotic symptoms. During mood episodes (lasting 2-4 weeks), Mr. K becomes grandiose, sleeps 2-3 hours nightly, speaks rapidly, and spends excessively on recording equipment. Between mood episodes, he continues to hear voices commenting on his actions and maintains the belief that recording industry executives are monitoring him. He has been hospitalized twice for manic episodes with psychotic features. During his most recent 4-month period between mood episodes, he remained convinced that his apartment was under surveillance and heard intermittent auditory hallucinations, though his mood was euthymic and his sleep and energy were normal.

Past Psychiatric History: Two prior psychiatric hospitalizations for manic episodes. Treated with lithium and risperidone with partial response. Discontinued medications 6 months ago due to side effects.

Family History: Mother diagnosed with Bipolar I Disorder. Paternal uncle diagnosed with Schizophrenia.

Substance Use: Occasional cannabis use. Denies other substances. Last use 3 weeks ago.

Mental Status Exam: Alert, oriented x3. Speech pressured, loud. Mood "incredible." Affect elevated, expansive causing with intermittent irritability. Thought process tangential with loosening of associations. Auditory hallucinations (running commentary). Persecutory and grandiose delusions present. Insight absent. Judgment impaired.

Step 1: Establishing Psychotic Symptoms Independent of Mood Episodes

The defining feature of Schizoaffective Disorder in DSM-5-TR is Criterion B: delusions or hallucinations for 2 or more weeks in the absence of a major mood episode during the lifetime duration of the illness. This temporal criterion is the primary differentiator from Bipolar I with psychotic features, where psychosis occurs exclusively during mood episodes.

Criterion A: An uninterrupted period of illness during which there is a major mood episode concurrent with Criterion A of schizophrenia.

Mr. K currently presents with a manic episode (grandiosity, decreased sleep, pressured speech, excessive spending) concurrent with Criterion A symptoms (auditory hallucinations, persecutory delusions). MET.

Criterion B: Delusions or hallucinations for 2 or more weeks in the absence of a major mood episode during the lifetime duration of illness.

During his most recent inter-episode period (4 months), Mr. K maintained persecutory delusions and experienced auditory hallucinations while his mood, sleep, and energy were at baseline. This 4-month period of psychosis without mood symptoms exceeds the 2-week minimum. MET.

Criterion C: Symptoms that meet criteria for a major mood episode are present for the majority of the total duration of the active and residual portions of the illness.

Review of the 3-year illness course indicates mood episodes (manic and depressive) have occupied approximately the majority of the total illness duration. Psychotic symptoms have been present during and between mood episodes. MET.

Criterion D: The disturbance is not attributable to the effects of a substance or another medical condition.

Cannabis use is occasional and last use was 3 weeks prior. Psychotic symptoms persist well beyond any substance effect window. No medical conditions identified. MET.

Step 2: Differentiating from Bipolar I with Psychotic Features

The critical distinguishing question: Do psychotic symptoms occur ONLY during mood episodes, or do they persist independently?

Feature Schizoaffective Disorder Bipolar I + Psychotic Features This Patient
Psychosis timing Present during AND between mood episodes Present ONLY during mood episodes Schizoaffective: psychosis persists between episodes
2+ weeks psychosis without mood Required (Criterion B) Does not occur Schizoaffective: 4-month inter-episode psychosis
Mood episodes Present for majority of illness Present episodically Mood episodes present for majority of illness course
Psychosis content May be mood-incongruent Typically mood-congruent Mixed: grandiose (congruent) + persecutory (incongruent)
Inter-episode functioning Often impaired Typically returns to baseline Schizoaffective: persistent functional impairment
Family history Schizophrenia and mood disorders Primarily mood disorders Both: mother Bipolar I, uncle Schizophrenia

Differential Summary

The 4-month period of persistent psychosis during euthymic mood definitively satisfies Criterion B and rules out Bipolar I Disorder with psychotic features, where psychosis resolves with mood normalization.

Diagnostic Formulation

Diagnostic Conclusion

Schizoaffective Disorder, Bipolar Type (F25.0): All four criteria met. Psychotic symptoms persist independently of mood episodes (Criterion B), mood episodes present for the majority of illness duration (Criterion C), manic episodes define the bipolar subtype. ICD-10 code F25.0.

Teaching Points

  • Schizoaffective Disorder requires meticulous longitudinal assessment. The 2-week minimum of psychosis without mood symptoms (Criterion B) cannot be evaluated from a single cross-sectional presentation. Collateral history from family members and review of prior treatment records are essential.
  • DSM-5-TR Criterion C (mood symptoms present for the majority of the illness) was added to prevent overdiagnosis of Schizoaffective Disorder in patients with Schizophrenia and brief depressive episodes. If mood episodes occupy only a small fraction of the illness, Schizophrenia with comorbid depressive episodes is more appropriate.
  • The bipolar subtype of Schizoaffective Disorder is specified when manic episodes are part of the presentation. The depressive subtype applies when only major depressive episodes occur (without manic or mixed episodes).
  • Treatment typically requires both a mood stabilizer (lithium, valproate) and an antipsychotic (second-generation preferred). Antipsychotic monotherapy may address psychosis but leaves mood cycling undertreated; mood stabilizer monotherapy addresses cycling but leaves psychosis undertreated.
  • Family history patterns can inform the differential: families with both schizophrenia spectrum and mood disorder diagnoses increase the prior probability of schizoaffective disorder.